Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO
Holding NWBO?
Track your performance easily

Northwest Biotherapeutics (NWBO) Stock Price & Analysis

405 Followers

NWBO Stock Chart & Stats


Financials

Annual

Ownership Overview

9.32%<0.01%0.05%90.61%
0.05% Other Institutional Investors
90.61% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

NWBO FAQ

What was Northwest Biotherapeutics’s price range in the past 12 months?
Northwest Biotherapeutics lowest stock price was $0.29 and its highest was $1.09 in the past 12 months.
    What is Northwest Biotherapeutics’s market cap?
    Currently, no data Available
    When is Northwest Biotherapeutics’s upcoming earnings report date?
    Northwest Biotherapeutics’s upcoming earnings report date is May 16, 2018 which is 2317 days ago.
      How were Northwest Biotherapeutics’s earnings last quarter?
      Currently, no data Available
      Is Northwest Biotherapeutics overvalued?
      According to Wall Street analysts Northwest Biotherapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Northwest Biotherapeutics pay dividends?
        Northwest Biotherapeutics does not currently pay dividends.
        What is Northwest Biotherapeutics’s EPS estimate?
        Northwest Biotherapeutics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Northwest Biotherapeutics have?
        Northwest Biotherapeutics has 1,248,237,300 shares outstanding.
          What happened to Northwest Biotherapeutics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Northwest Biotherapeutics?
          Currently, no hedge funds are holding shares in NWBO
          ---

          Northwest Biotherapeutics Stock Smart Score

          Company Description

          Northwest Biotherapeutics

          Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Brainstorm Cell Therapeutics
          China Pharma Holdings
          TRACON Pharmaceuticals
          Plus Therapeutics
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis